 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

ImmunoPrecise Antibodies announce board and committee chair appointments

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (ImmunoPrecise or IPA or the Company), a leader in AI-driven biotherapeutic research and technology, is pleased to announce important Board of Director...

ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call

VICTORIA, BC / ACCESSWIRE / November 22, 2023 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand...

ImmunoPrecises BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA  Get Free Report)s stock price was down 9.9% during mid-day trading on Thursday . The company traded as low as $1.86 and last traded at $1.91...

ImmunoPrecise Antibodies (NASDAQ:IPA)  Shares Down 9.9%

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (ImmunoPrecise or IPA or the Company), an AI-driven biotherapeutic research and technology company, announces that its subsidiary, BioStrand, has...

IPAs Subsidiary, BioStrand, Provides an Update on LENSai

VICTORIA, BC / ACCESSWIRE / October 20, 2023 / Biotechnology research involves a vast amount of complex information that spans different dimensions, such as the functions of proteins, the 3D...

Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data

VICTORIA, BC / ACCESSWIRE / October 13, 2023 / The introduction of artificial intelligence (AI) in healthcare has revolutionized the field, allowing for a more personalized approach to patient care...

How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced financial results for first quarter fiscal year...

IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its...

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023

Shares of ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA  Get Free Report) traded down 0.4% during trading on Friday . The company traded as low as $2.26 and last traded at $2.27. 5,488 shares were traded during mid-day trading, a decline of 91% from the average session volume of 58,257 shares. ...

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Down 0.4%

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.

Watchers	3,091
52-Wk Low	$1.14
52-Wk High	$5.90

Market Cap	$42.59M
Volume (M)	51,098.00
52-Wk High	$5.90
52-Wk Low	$1.14

IPA ImmunoPrecise Antibodies Ltd

About

Feed

News

Earnings

Fundamentals